Clinical Trials Directory

Trials / Completed

CompletedNCT06110702

Effects of an EMDR Intervention on Traumatic and Obsessive Symptoms

Randomized Trial on the Effects of an EMDR Intervention on Traumatic and Obsessive Symptoms During the COVID19 Quarantine: a Psychometric Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
287 (actual)
Sponsor
University of Pisa · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

The Eye Movement Desensitization and Reprocessing Protocol (EMDR) was first developed by Francine Shapiro in 1987 and can be adapted for online and in presence administration. The aim of this study is to assess if a EMDR program (administered both online and in presence, depending on different conditions of patients) may help people recruited from general population suffering from COVID19 second (November 2021 to February 2022) and third (March 2022 to May 2022) quarantine in improving post-traumatic stress (PTSD) and obsessive-compulsive-related (OCD) symptoms, as well as disgust, guilt, shame and their subjective unit of distress (SUD) and validity of cognition (VoC) levels.

Conditions

Interventions

TypeNameDescription
BEHAVIORALEMDREye movement Desensitization and Reprocessing (as described in the 8-phases protocol), administered both online or in presence.

Timeline

Start date
2021-10-10
Primary completion
2022-04-30
Completion
2022-04-30
First posted
2023-11-01
Last updated
2024-04-16

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06110702. Inclusion in this directory is not an endorsement.